Last reviewed · How we verify
COVID-19 standard care
At a glance
| Generic name | COVID-19 standard care |
|---|---|
| Also known as | Current COVID-19 standard care in the UAE |
| Sponsor | Abu Dhabi Stem Cells Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 (PHASE2)
- LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma (EARLY_PHASE1)
- I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients (PHASE2)
- Nasal Swab Objective and Statistical Evaluation (NOSE Study)
- Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients (NA)
- COVID-19 Rapid Test-to-Treat With African American Churches (Faithful Response II) (PHASE2)
- Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19) (NA)
- Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia. (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |